Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with decreased muscle strength and physical function

Barbara S Van der Meij, Nicolaas Deutz, Ramon Rodriguez, Fari Koeman, Tiffany Smit, Marielle Engelen

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Abstract

Rationale: Weight loss and muscle wasting are common in cancer patients and negatively affect physical function andquality of life. This study investigates the relationship between protein metabolism, muscle strength and physical functionin patients with advanced cancer.Methods: In 16 patients with solid tumours (C) and 16 age- and gender-matched healthy controls (H), we assessedfasted whole body net protein breakdown (netPB), myofibrillar PB (MPB) and rate of appearance (Ra) by pulse IVadministration of stable tracers ([2H3]tau-methylhistidine, 2H3-LEU, 2H2-GLY). We measured net protein synthesis (netPS),and protein digestion (PD: gut function) after intake of a high-protein meal with [1-13C]PHE and 15N-spirulina and primed continuous infusion of [ring-2H5]PHE and [13C9-15N]TYR. We tested FFM-i, handgrip, inspiratory,hand and leg musclestrength, physical activity by PASE and physical function by EORTC-QLQc30 questionnaires. Amino acid concentrations/enrichments by LC-MS/MS, and statistics by unpaired t-tests and spearman correlation tests.Results: FFM-i, handgrip strength and physical activity were similar in C and H, leg and inspiratory muscle strength werelower in C (p<0.05). Fasted netPB (5.9 vs. 6.8 μmol/kg ffm/h), fed netPS (40.2 vs. 43.9 μmol/kg ffm/h) and proteindigestion were not different, MPB and leucine Ra (0.29 vs.0.20 and 114.3 vs. 66.3 μmol/kg ffm/h) and clearance (0.07 vs.0.04 and 1.42 vs. 0.78 L/min) and glycine clearance (1.3 vs. 0.9 L/min) were higher in C (P<0.05). In C Ra-glycine wasassociated with leg extension strength (r=0.51, P=0.06), glycine clearance with impaired physical function (r=-0.59,P=0.04).Conclusion: Patients with advanced cancer with preserved muscle mass and physical activity have an increased aminoacid turnover and myofibrillar protein breakdown, negatively impacting muscle strength and physical function.
Original languageEnglish
Pages (from-to)S46-S47
Number of pages2
JournalClinical Nutrition
Volume36
Issue numberSupplement 1
DOIs
Publication statusPublished - Sep 2017
EventThe 39th European Society for Clinical Nutrition and Metabolism Congress 2017 - Hague, Netherlands
Duration: 9 Sep 201712 Sep 2017
Conference number: 39
http://www.espen.org/congress/next-congresses/12-espen/index.php?option=com_content&view=article&id=214&Itemid=1052

Fingerprint

Muscle Strength
Amino Acids
Neoplasms
Proteins
Glycine
Leg
Exercise
Methylhistidines
Spirulina
Muscles
Leucine
Proteolysis
Meals
Weight Loss
Hand
Heart Rate

Cite this

Van der Meij, Barbara S ; Deutz, Nicolaas ; Rodriguez, Ramon ; Koeman, Fari ; Smit, Tiffany ; Engelen, Marielle. / Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with decreased muscle strength and physical function. In: Clinical Nutrition. 2017 ; Vol. 36, No. Supplement 1. pp. S46-S47.
@article{826c7ccfeff244d0b4897278c526b2e0,
title = "Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with decreased muscle strength and physical function",
abstract = "Rationale: Weight loss and muscle wasting are common in cancer patients and negatively affect physical function andquality of life. This study investigates the relationship between protein metabolism, muscle strength and physical functionin patients with advanced cancer.Methods: In 16 patients with solid tumours (C) and 16 age- and gender-matched healthy controls (H), we assessedfasted whole body net protein breakdown (netPB), myofibrillar PB (MPB) and rate of appearance (Ra) by pulse IVadministration of stable tracers ([2H3]tau-methylhistidine, 2H3-LEU, 2H2-GLY). We measured net protein synthesis (netPS),and protein digestion (PD: gut function) after intake of a high-protein meal with [1-13C]PHE and 15N-spirulina and primed continuous infusion of [ring-2H5]PHE and [13C9-15N]TYR. We tested FFM-i, handgrip, inspiratory,hand and leg musclestrength, physical activity by PASE and physical function by EORTC-QLQc30 questionnaires. Amino acid concentrations/enrichments by LC-MS/MS, and statistics by unpaired t-tests and spearman correlation tests.Results: FFM-i, handgrip strength and physical activity were similar in C and H, leg and inspiratory muscle strength werelower in C (p<0.05). Fasted netPB (5.9 vs. 6.8 μmol/kg ffm/h), fed netPS (40.2 vs. 43.9 μmol/kg ffm/h) and proteindigestion were not different, MPB and leucine Ra (0.29 vs.0.20 and 114.3 vs. 66.3 μmol/kg ffm/h) and clearance (0.07 vs.0.04 and 1.42 vs. 0.78 L/min) and glycine clearance (1.3 vs. 0.9 L/min) were higher in C (P<0.05). In C Ra-glycine wasassociated with leg extension strength (r=0.51, P=0.06), glycine clearance with impaired physical function (r=-0.59,P=0.04).Conclusion: Patients with advanced cancer with preserved muscle mass and physical activity have an increased aminoacid turnover and myofibrillar protein breakdown, negatively impacting muscle strength and physical function.",
author = "{Van der Meij}, {Barbara S} and Nicolaas Deutz and Ramon Rodriguez and Fari Koeman and Tiffany Smit and Marielle Engelen",
year = "2017",
month = "9",
doi = "10.1016/S0261-5614(17)30674-X",
language = "English",
volume = "36",
pages = "S46--S47",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",
number = "Supplement 1",

}

Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with decreased muscle strength and physical function. / Van der Meij, Barbara S; Deutz, Nicolaas; Rodriguez, Ramon; Koeman, Fari; Smit, Tiffany; Engelen, Marielle.

In: Clinical Nutrition, Vol. 36, No. Supplement 1, 09.2017, p. S46-S47.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

TY - JOUR

T1 - Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with decreased muscle strength and physical function

AU - Van der Meij, Barbara S

AU - Deutz, Nicolaas

AU - Rodriguez, Ramon

AU - Koeman, Fari

AU - Smit, Tiffany

AU - Engelen, Marielle

PY - 2017/9

Y1 - 2017/9

N2 - Rationale: Weight loss and muscle wasting are common in cancer patients and negatively affect physical function andquality of life. This study investigates the relationship between protein metabolism, muscle strength and physical functionin patients with advanced cancer.Methods: In 16 patients with solid tumours (C) and 16 age- and gender-matched healthy controls (H), we assessedfasted whole body net protein breakdown (netPB), myofibrillar PB (MPB) and rate of appearance (Ra) by pulse IVadministration of stable tracers ([2H3]tau-methylhistidine, 2H3-LEU, 2H2-GLY). We measured net protein synthesis (netPS),and protein digestion (PD: gut function) after intake of a high-protein meal with [1-13C]PHE and 15N-spirulina and primed continuous infusion of [ring-2H5]PHE and [13C9-15N]TYR. We tested FFM-i, handgrip, inspiratory,hand and leg musclestrength, physical activity by PASE and physical function by EORTC-QLQc30 questionnaires. Amino acid concentrations/enrichments by LC-MS/MS, and statistics by unpaired t-tests and spearman correlation tests.Results: FFM-i, handgrip strength and physical activity were similar in C and H, leg and inspiratory muscle strength werelower in C (p<0.05). Fasted netPB (5.9 vs. 6.8 μmol/kg ffm/h), fed netPS (40.2 vs. 43.9 μmol/kg ffm/h) and proteindigestion were not different, MPB and leucine Ra (0.29 vs.0.20 and 114.3 vs. 66.3 μmol/kg ffm/h) and clearance (0.07 vs.0.04 and 1.42 vs. 0.78 L/min) and glycine clearance (1.3 vs. 0.9 L/min) were higher in C (P<0.05). In C Ra-glycine wasassociated with leg extension strength (r=0.51, P=0.06), glycine clearance with impaired physical function (r=-0.59,P=0.04).Conclusion: Patients with advanced cancer with preserved muscle mass and physical activity have an increased aminoacid turnover and myofibrillar protein breakdown, negatively impacting muscle strength and physical function.

AB - Rationale: Weight loss and muscle wasting are common in cancer patients and negatively affect physical function andquality of life. This study investigates the relationship between protein metabolism, muscle strength and physical functionin patients with advanced cancer.Methods: In 16 patients with solid tumours (C) and 16 age- and gender-matched healthy controls (H), we assessedfasted whole body net protein breakdown (netPB), myofibrillar PB (MPB) and rate of appearance (Ra) by pulse IVadministration of stable tracers ([2H3]tau-methylhistidine, 2H3-LEU, 2H2-GLY). We measured net protein synthesis (netPS),and protein digestion (PD: gut function) after intake of a high-protein meal with [1-13C]PHE and 15N-spirulina and primed continuous infusion of [ring-2H5]PHE and [13C9-15N]TYR. We tested FFM-i, handgrip, inspiratory,hand and leg musclestrength, physical activity by PASE and physical function by EORTC-QLQc30 questionnaires. Amino acid concentrations/enrichments by LC-MS/MS, and statistics by unpaired t-tests and spearman correlation tests.Results: FFM-i, handgrip strength and physical activity were similar in C and H, leg and inspiratory muscle strength werelower in C (p<0.05). Fasted netPB (5.9 vs. 6.8 μmol/kg ffm/h), fed netPS (40.2 vs. 43.9 μmol/kg ffm/h) and proteindigestion were not different, MPB and leucine Ra (0.29 vs.0.20 and 114.3 vs. 66.3 μmol/kg ffm/h) and clearance (0.07 vs.0.04 and 1.42 vs. 0.78 L/min) and glycine clearance (1.3 vs. 0.9 L/min) were higher in C (P<0.05). In C Ra-glycine wasassociated with leg extension strength (r=0.51, P=0.06), glycine clearance with impaired physical function (r=-0.59,P=0.04).Conclusion: Patients with advanced cancer with preserved muscle mass and physical activity have an increased aminoacid turnover and myofibrillar protein breakdown, negatively impacting muscle strength and physical function.

U2 - 10.1016/S0261-5614(17)30674-X

DO - 10.1016/S0261-5614(17)30674-X

M3 - Meeting Abstract

VL - 36

SP - S46-S47

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - Supplement 1

ER -